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ABSTRACT 
Objective: Vulvodynia is a chronic pain condition characterised by severe pain affecting the 
vulva. Biopsychosocial models have revealed the importance of illness perceptions, 
cognitive-behavioural variables and psychological distress in explaining the experience of 
pain and disability across several conditions. These factors have never been collectively 
examined in Vulvodynia. We predicted that distress, fatigue, illness perceptions, and 
cognitive-behavioural factors would be associated with pain severity and interference among 
women with Vulvodynia. 
Methods: This online cross-sectional study recruited 335 Vulvodynia patients from an Italian 
charity association (Vulvodiniapuntoinfo.com), who completed pain severity and interference 
measures in addition to the Hospital Anxiety and Depression scale, Revised Illness Perception 
Questionnaire, Chalder Fatigue Questionnaire, Cognitive-Behavioural Symptom 
Questionnaire and a demographic questionnaire. 
Results: Hierarchical regression models controlling for demographic and illness characteristics, 
revealed that lower treatment control beliefs, greater illness identity, catastrophizing and 
psychological distress, were significant predictors of pain severity, explaining 35% of the 
variance. A second adjusted hierarchical regression model revealed that low treatment-control, 
higher fatigue, distress, and avoidance/resting behaviours were significant predictors of pain 
interference, explaining 48% of the variance. 
Conclusion: Distress, illness perceptions, fatigue, and cognitive-behavioural factors are 
associated with pain severity and interference in Vulvodynia patients, highlighting the 
importance of adopting a biopsychosocial approach in this setting. Future research should 
examine these factors over time to inform the development of future tailored interventions to 
help support women better manage Vulvodynia.  
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INTRODUCTION 
Vulvodynia is a chronic pain condition characterised by severe vulvar pain lasting more than 3 
months, referred to as burning and cutting (knife-like) pain. The prevalence of Vulvodynia is 
15-18% (1) with an elusive aetiology (2). According to the International Society for the Study 
of Vulvovaginal disease (ISSVD) (2), Vulvodynia can be classified as generalised (involving 
the whole general area), localised in one area such as the Vestibule (Vestibulodynia) or mixed 
(localised and generalised). This can be further divided by how the pain arises, either 
spontaneous, provoked (i.e. triggered by a stimulus such as sexual intercourse) or mixed 
(spontaneous and provoked). 
Similar to patients with neuropathic pain conditions, women with Vulvodynia present 
with allodynia and hyperalgesia (3), therefore dyspareunia and pain occur during normal daily 
activities. Whilst the aetiology is still unclear, conceivable factors include abnormal 
inflammatory response in the vestibule and an increased number and superficialization of pain 
fibers (4,5) due to genetic polymorphisms associated with functional alterations to IL-1β and 
TNF-α (6), as well as the presence of recurrent infections due to an altered distribution of 
mannose-binding lectin (7).  
Since women with Vulvodynia are faced with severe long-term pain, it is not surprising 
that it poses multiple challenges for their psychological health. However, there is limited 
research examining psychological factors associated with Vulvodynia. The lack of research 
might be partly explained by the fact that Vulvodynia is still conceptualised in a dualistic 
fashion: either as a psychogenic sexual condition or a biomedical condition. While there is 
increasing recognition regarding the contribution of psychosocial and behavioural factors in 
several chronic pain conditions (8,9), a biopsychosocial approach to understanding Vulvodynia 
has not been widely considered. 
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Within Vulvodynia, studies have mostly focused on the prevalence of depression and 
anxiety in this population. The prevalence of psychological distress in women with Vulvodynia 
has revealed inconsistent findings, with studies suggesting more anxiety and depression 
compared to healthy women (10,11), and some suggesting no differences (12). The only study 
to our knowledge investigating the relation between pain and distress (13) suggests an 
association between depression and the severity of Vulvodynia.  
Importantly, while recent advances in other conditions such as chronic lower back pain 
has identified the importance of catastrophizing, fear and hypervigilance in the aetiology of 
pain and its maintenance (14,15,16), these factors have not been examined in women with 
Vulvodynia and only once among Vestibulodynia women (17). According to the fear-avoidance 
model, pain-catastrophizing leads to fear of pain, resulting in the use of maladaptive coping 
strategies such as avoidance of activities which may cause pain. Long-term avoidance, however 
results in deconditioning and lower mood, all factors lowering the threshold at which 
subsequent pain will be experienced, thus contributing to pain chronicity and exacerbation of 
catastrophic thoughts. Among Vestibulodynia women, the only study conducted in this domain 
(17) found that catastrophizing, anxiety, fear of pain, and hypervigilance collectively explained 
15% of variance in intercourse pain, but that only pain-catastrophizing contributed unique 
variance to this outcome. This suggests that whilst pain-catastrophizing is important, other 
factors might play a role.  
Of potential importance is the role of illness perceptions in response to symptoms. 
However, to date, illness perceptions among women with Vulvodynia have not been evaluated. 
According to the Common-Sense Model of illness representations (CSM), illness perceptions 
refer to cognitions that individuals have surrounding an illness or symptom(s) (in the current 
study perceptions surrounding Vulvodynia), which then guide individuals’ coping behaviours 
to manage and control their conditions (18). Illness perceptions consist of the following 
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dimensons:1) identity (Beliefs concerning the illness label and symptoms attributed to the 
condition); (2) cause (beliefs about causes of the illness); (3) timeline (the perceived duration 
of the illness, cyclical, acute or chronic); (4) consequences (beliefs about the effects of the 
illness), (5) control/cure (beliefs regarding the controllability/curability of the illness); (6) 
coherence (understanding of the illness). To date, there is robust evidence demonstrating the 
importance of examining illness perceptions in relation to health outcomes across several 
conditions (19, 20). For instance, among orofacial pain patients and osteoarthritis patients 
(21,22), negative illness perceptions at baseline were predictive of higher pain-related disability 
after 6 months and 6 years respectively, suggesting these could be worth exploring in 
Vulvodynia.                                                                                                                                                           
                     Biopsychosocial models have been show to explain variability in symptoms 
across a range of conditions (23,24). For example, Multiple Sclerosis (MS) fatigue (23), is 
associated with that negative cognitions in responses to fatigue symptoms can lead to negative 
emotions, which in turn manifest themselves in maladaptive behaviours, such as all-or-nothing 
(over-exertion followed by excessive rest) and avoidance behaviours, creating a vicious cycle 
ultimately exacerbating and maintaining fatigue. Within acute and chronic pain conditions fear-
avoidance beliefs and distress is associated with greater disability (25). Furthermore, 
behavioural avoidance has been associated with greater distress and disability amongst those 
with chronic pain (26). Despite promising findings elsewhere no studies have explored these 
factors in relation to pain in Vulvodynia patients. 
                     Collectively, the lack of Vulvodynia research requires an urgent need for 
expansion to give an insight into the contributions of psychological and behavioural factors in 
women’s experience of pain. Furthermore, given the success of tailored psychological 
interventions on other chronic conditions (27,28), it is of paramount importance to investigate 
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the contributions of these factors which will help inform the future development of 
interventions designed to help support women manage their pain.  
The overarching objective of this study was to evaluate a biopsychosocial approach in 
women with Vulvodynia, examining factors associated with the variability of pain severity and 
interference. Given the findings of past studies investigating the role of psychological and 
behavioural factors in other long-term conditions we tested the following hypotheses: 
 
1. Psychological distress, as measured by depression and anxiety symptoms, and fatigue 
would be associated with greater pain severity and interference. 
2. Negative illness perceptions, higher levels of catastrophizing, fear-avoidance, damage 
beliefs, symptoms-focusing, embarrassment-avoidance and greater use of all-or-
nothing behaviour and avoidance/resting behaviours would all be associated with 
greater levels of pain severity and inference.   
METHOD 
Study Design and procedure 
This study employed an online cross-sectional design. The primary outcome variables were 
self-reported pain severity and pain interference. Participants completed these and other 
questionnaires (described below) online, using Bristol online Survey (BOS). The study 
received approval by King’s College London committee in June 2016. 
Participants 
Vulvodynia patients were recruited through media announcements from 
Vulvoduniapuntoinfo.com, an Italian non-profit organization on Vulvodynia. Participants were 
considered eligible providing the following: 1) presence of Vulvodynia diagnosis from a health 
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professional (all subtypes of Vulvodynia were eligible), 2) participants were still suffering from 
the condition, 3) participants were over 18, 4) participants were fluent in Italian. No upper age 
limit was set as Vulvodynia can affect women of any age (1). Participants with a comorbid 
condition were considered eligible. Participants were considered ineligible if the following 
were present: lack of a Vulvodynia diagnosis from a health professional (2) participants were 
diagnosed with Vulvodynia in the past but fully recovered, (3) pregnant, (4) insufficient fluency 
in Italian (5) being under 18. 
 Materials: 
Questionnaires measures- Dependent variables 
Pain severity (primary outcome) 
Participants’ pain severity was assessed through a Numeric Pain Rating Scale (NPRS) consist-
ing of four questions measuring the severity of the pain experienced (29). Each of the following 
items was rated on a scale where 0 is “no pain” and 10 is “extremely intense pain (How intense 
is your pain right now?; How intense was your pain on average last week?; How distressing 
is your pain right now?; How distressing was your pain on average last week?). The question-
naire was back-translated. Internal reliability was high (=.93). 
 
Pain interference (primary outcome) 
The Brief-Pain Inventory (interference scale) was used to measure participants’ pain 
interference (30). This scale measures the extent pain interferes with the following aspects of 
one’s life over the course of the past week: general activity, mood, normal work, relationships 
with people, sleep, enjoyment of life. For each of these domains, a person is asked to choose 
the rate the degree pain has interfered on a scale from 0 to 10, where 0 is “does not interfere” 
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and 10 is “completely interferes”. The scale was back-translated and its internal reliability was 
=.90. 
 
Questionnaires- Independent variables 
Illness Perception Questionnaire-Revised (IPQ-R) 
The IPQ-R (31) was used to measure participants' illness perceptions (i.e. Vulvodynia). The 
IPQ-R measures the following illness representations: Illness identity was measured by 14 
symptoms in which patients had to report whether they experienced the symptoms and if so 
whether they attributed the symptom to Vulvodynia. The number of symptoms attributed to 
Vulvodynia were summed (range 0-14), with higher scores indicating increased illness identity. 
The following dimensions were measured on a five point likert scale (strongly disagree- 
strongly agree); Consequences (e.g. “my Vulvodynia has major consequences on my life”), 
Emotional representations (e.g. “I get depressed when I think about my Vulvodynia”), Timeline 
(e.g. “my Vulvodynia will last for a long time”), Cyclical timeline (e.g. “my Vulvodynia 
symptoms come and go in cycles”), Illness coherence (e.g. “my Vulvodynia is a mystery to 
me”), Personal Control (e.g. “I have the power to influence my Vulvodynia”) and Treatment 
Control (e.g. “my treatment can control my Vulvodynia”). In this study, the Italian version of 
the IPQ-R was used (32). The internal reliability of each sub-scale was high (s>.80), with the 
exceptions of consequences (= .66) and personal control (= .60). 
 
Hospital anxiety and depression scale (HADS) 
HADS was used to measure participants' psychological distress (depression and anxiety) (33). 
Due to the high correlation between anxiety and depression sum scales, a total HADS score 
was computed with high scores representing greater levels of distress. The HADS was back 
translated and had high internal reliability for the total score (=.80). 
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Cognitive-Behavioural Symptom Questionnaire (CBSQ) 
The CBSQ (34) is a self-report questionnaire measuring patient’s cognitive and behavioural 
responses to symptoms (in this case pain). The CBSQ contains 40-items which are added to 
form five cognitive subscales; fear avoidance (e.g. “Avoiding unnecessary activities is the 
safest thing I can do to prevent my symptoms from worsening”), embarrassment avoidance 
(e.g. “I am embarrassed about my symptoms”), catastrophizing about symptoms (e.g. “I think 
that if my symptoms get too severe they may never decrease”), beliefs that symptoms signal 
damage to the body (damage beliefs, e,g. “the severity of my symptoms must mean there is 
something serious going on in my body”), and symptom focus (e.g. “my symptoms are always 
at the back of my mind”). There are also two behavioural subscales; resting and avoidance of 
activity (e.g. “I tend to avoid activities that make my symptoms worse), and all-or-nothing 
behaviour (e.g. “I tend to overdo things when I feel energetic”). All items are rated on a 5 point 
Likert scale ranging from “strongly disagree” to “strongly agree”. The questionnaire was back-
translated and the internal reliabilities of each subscale was acceptable (all s > .72). 
 
Chalder Fatigue Questionnaire (CFQ) 
        CFQ (35) was used to measure participants’ fatigue. CFQ is an 11-item questionnaire 
measuring the severity of physical and mental fatigue. Seven items represent physical fatigue 
(items 1–7) and 4 represent mental fatigue (items 8–11). In this study, binary scoring was used. 
Each item is scored from “better than usual (0) to “much worse than usual (1)”. Scores of the 
items were added to calculate the total (range=0–11) with scores of 4 indicating high levels 
(“caseness”) of fatigue. The questionnaire was back-translated and had high internal reliability 
= .91. 
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Demographic and clinical data 
Demographic and clinical factors were measured through a self-report questionnaire. The 
questionnaire consists of 20 questions measuring participants’ age, nationality, employment 
status, characteristics of Vulvodynia (e.g. onset, presence of a diagnosis) and details of any 
physical health comorbidities. The number of comorbidities reported was totalled to form a 
comorbidity score, where higher scores indicate greater comorbidity. 
STATISTICAL METHODS 
       No data was missing. All data was analysed using SPSS version 22.  Factors associated 
with pain severity and pain interference were evaluated using two multiple linear regression 
models. Variables were entered in final regression models using a hierarchical method, using a 
two-block variable entry method. Block 1 adjusted for demographic and clinical factors (level 
of education, age, years living with diagnosis and comorbidity). The second block included the 
psychological variables under investigation. The emotional representation variable of the IPQ-
R was excluded from the analyses as it overlaps with distress (HADs). Model improvement 
was evaluated using ΔF-statistic. Improvement in explained variance was calculated using ΔR2. 
Statistical significance level was assumed at p< 0.05. 
RESULTS 
Patient characteristics 
               338 participants took part and provided informed consent. However, 3 patients were 
removed from the analysis because they lacked a current Vulvodynia diagnosis. A summary of 
demographic and clinical information is presented in Tables 1 and 2 respectively (n=335). The 
mean age was 34.8 years (SD=9.6) and predominantly of White ethnic origin (94%). The ma-
jority of participants were Italian (96.7%), among which 58% were employed, 18.5% students, 
and 18.5% unemployed. Participants' mean duration of symptom onset was 6.5 years (Median= 
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5.0; Interquartile range [IQR]= 5.7), and mean duration since Vulvodynia diagnosis was 3 years 
(Median= 2.0; IQR= 3.0). 83.6% of participants were on some form of prescribed treatment 
for the condition. 240 (72%) scored 4 on the Chalder fatigue questionnaire indicating clini-
cally significant levels of fatigue.  
 
Demographic and clinical correlates of pain severity and interference 
               Univariate analyses were conducted examining the associations between 
demographic, illness-related characteristics with the outcome variables. Age was not 
significantly correlated with pain severity and interference (r=-.06, p=.269 and r=-.06 and 
p=.276 respectively). Likewise, years living with the diagnosis was not significantly correlated 
with pain severity and interference, nor was the number of years living with symptoms. Those 
with a higher education (university) reported lower pain (mean difference=3.74, p<0.01) and 
less pain inference (mean difference=5.97, p<0.01) compared to those without a university 
level education. Greater comorbidity was associated with higher pain (r=.18, p<0.01) and pain 
interference (r=.24, p<0.01).   
Psychological correlates of pain severity and interference 
            Correlates between psychosocial factors and the outcome variables are shown in Table 
3, accompanied by descriptive statistics. All the psychosocial variables, except for cyclical-
timeline (with pain severity; r=-.01, p=.818), were significantly correlated with pain severity 
and pain interference. Pain severity and pain interference correlated strongly (r=.71, p=.001). 
Correlations between all the psychosocial variables are shown in appendix Table 1a.  
 Multivariate regression: factors associated with pain severity 
                    Psychological factors significantly associated with pain severity, with a correlation 
of .2 or more were included in the first hierarchical regression model of pain severity. This was 
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to ensure the model was not over fitted by entering too many independent variables. Therefore, 
fear-avoidance, all-or-nothing behaviour, timeline (acute/chronic), coherence, cyclical-
timeline were excluded from the analysis. The first step in the pain severity model controlled 
for demographic and illness characteristics, that showed univariate associations with pain 
severity (Table 4). A higher level of education was found to be a significantly associated with 
lower pain severity. Furthermore, greater co-morbidity and younger age were associated with 
higher pain severity. This model was found to explain 6.3% of the variance (F=3.76, p<0.01). 
Adding the psychosocial factors into the model significantly improved the model (F=12.0, 
p<0.01), explaining an additional 28.3% of the variance in pain severity (R² =.35). In the fully-
adjusted model education and co-morbidity ceased to be significantly associated with pain 
severity. Higher levels of psychological distress, catastrophizing and illness identity were 
associated with greater pain severity, while lower levels treatment-control were associated with 
greater pain severity.  
Multivariate regression: factors associated with pain interference 
                   The second hierarchical regression included all the variables significantly 
correlated with pain interference. The following variables, due to correlation coefficients being 
<.2, were excluded: timeline (acute/chronic), personal-control, and cyclical-timeline. Block 1, 
controlled for demographic and illness characteristics, that showed univariate associations with 
pain interference (Table 5). The model was found to explain 8.4% of variance in pain 
interference (F=7.56, p<0.01). Only education and comorbidity were a significantly associated 
with pain interference. Adding the psychosocial factors into the model significantly improved 
the model (F= 17.23, p<0.01), explaining an additional 39.6% of the variance in pain severity 
(R²=.48). Greater psychological distress, fatigue and avoidance/resting behaviours were 
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significantly associated with greater pain interference. Lower treatment control was 
significantly associated with less pain interference.  
DISCUSSION 
              The current study explored the associations between psychological factors and the 
experience of pain and pan interference among women with Vulvodynia. Among demographic 
and illness characteristics, education was significantly associated with pain interference in the 
fully-adjusted model. In agreement with previous research (36), the relationships between 
education and both outcomes were found to act protectively, with more years of educations 
being associated with lower pain interference. Age was significantly associated with pain 
severity, with younger age associated with higher pain severity, which is consistent with 
previous pain studies (37, 38).   
                 As hypothesised, greater psychological distress was significantly associated with 
both increased pain severity and interference. The contribution of distress to pain severity and 
interference has been previously documented in other chronic pain conditions (39), but scarcely 
researched in Vulvodynia (17). Although speculative, it is possible that psychological distress 
could constitute a risk-factor for the onset of Vulvodynia, as there is evidence that women with 
antecedent depression are 4 times more likely to develop Vulvodynia (40). Depression is known 
to be associated with a lower pain threshold and altered immuno-inflammatory response 
mechanisms (41,42) which could also be involved in the aetiopathogenesis of Vulvodynia. 
Examining these relationships would be of interest in future studies to determine whether 
depression and its association with immune function, are implicated in the aetiology of 
Vulvodynia. 
                    With regards to illness perceptions, treatment-control was significantly associated 
with pain severity and interference, with lower perception of treatment-control associated with 
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higher levels of pain and pain interference. This is consistent with previous findings investi-
gating the role of illness perceptions and clinical outcomes in other populations (43). Whilst 
causality cannot be inferred here, based on the CSM (if-then rules (18), health behaviours such 
as adherence and lifestyle factors may act as potential mediators. Similarly, high illness identity 
was significantly associated with greater pain severity. This is consistent with previous research, 
where a tendency to attribute a wide range of symptoms has been found to be associated with 
worse health related outcomes among a variety of long-term conditions including, multiple 
sclerosis (44), rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis (45) 
and Fibromyalgia (46). Although the nature of this relationship cannot be examined within the 
current study, there is evidence that high illness identity is associated with maladaptive coping 
styles (47), possibly mediating the identity-health outcome relationship.  
                Lastly, personal-control had a marginal association with pain severity, with lower 
perceptions of personal control of Vulvodynia being associated with greater pain. The direction 
of this association is in line with previous research on chronic pain patients such rheumatoid 
arthritis (48), where lower control was associated with greater pain and disability. However, it 
should be noted personal control as measured by the IPQ-R, had low internal reliability in the 
current study limiting the interpretability of its association with the outcome variables. Overall, 
while the results of the current study support the role of illness representations and distress at 
explaining pain severity and interference among women with Vulvodynia, not all illness per-
ceptions revealed to be significantly associated with the outcomes, partially confirming this 
study’s hypothesis.  
With regards to cognitive-behavioural variables, catastrophizing was the only factor in 
adjusted analysis found to be a significant predictor of pain severity. These findings support 
past work (17), which has shown an association between catastrophizing and intercourse pain 
among women with vestibulodynia. Although it is not possible to determine the direction of 
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causality between catastrophizing and pain given our design, the study suggests the importance 
of targeting specific pain-related beliefs for the treatment of pain in this patient population and 
interventions that target catastrophizing (e.g., cognitive restructuring) may be beneficial in 
women with chronic vulval pain (49). Avoidance/resting behaviour was a significant predictor 
of pain interference. These findings partially support those of others in other pain conditions 
(25, 26), and suggest that avoidance of activity is associated with greater pain impact. 
Longitudinal studies in women with Vulvodynia are needed to examine the temporal 
relationships between these factors over time. 
             Lastly, while fatigue was not found to be a significant predictor of pain severity, it was 
significantly associated with pain interference, where higher levels of fatigue were associated 
with greater pain interference. Due to the lack of previous research investigating these 
associations on women with Vulvodynia, this represents the first study to yield these results. 
While causality cannot be inferred, it is possible that highly interfering pain may lead women 
to avoid doing activities, to rest more, causing physical deconditioning, and contributing to the 
experience of fatigue. It is worth exploring the potentially mediating role of rest and avoidance 
in this population in the future. 
                 Overall, the current study demonstrated that variation in pain and pain interference 
is associated with distress, illness perceptions and cognitive-behavioural factors. This factors 
appear to explain greater variance for pain interference than pain severity, suggesting they 
might be important interventional targets in order to reduce the impact of pain in Vulvodynia.  
Strengths and Limitations 
Strengths of this study include a large sample, especially in an under-studied population 
like Vulvodynia. Importantly, the study examined the presence of comorbid-pain conditions in 
the sample and adjusted for this in the analysis. This is also the first study investigating the role 
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of fatigue, cognitive-behavioural variables, psychological distress and illness perceptions in 
relation to pain severity and interference within Vulvodynia. Previous studies within chronic 
pain (47,50) have demonstrated the contributions of these factors in explaining pain; however, 
prior to this point no research has sought to explore these factors in this population. In a chronic 
pain condition like Vulvodynia, which affects 18% of women (1), exploring the patients’ beliefs 
and behaviours surrounding their illness is an important basis for understanding the relations 
between psychological factors and women’s pain. Our results highlight the importance of 
applying a biopsychosocial approach to understanding pain in Vulvodynia and should 
encourage longitudinal studies to determine which factors perpetuate and maintain symptoms 
over time. 
                Limitations of this study should also be noted. Firstly, the cross-sectional design does 
not allow to infer conclusions regarding the causality between the predictor and outcome 
variables. Secondly, although one of the most common and debilitating symptoms of 
Vulvodynia is intercourse pain, questions regarding this aspect of women’s life were not 
specifically addressed. Therefore, the questionnaires used might have failed to take into 
account the sexual aspects related to the condition. Further, whilst we used previously validated 
measurements, these have not been examined within this setting and several of the measures 
were translated here, possibly impacting upon the reliability of our findings. Clinical 
information was self-reported which is a further limitation as this could not be verified from 
medical records. Finally, despite the advantage of a large sample, there was limited external 
representativeness in regards to ethnicity since the sample was predominantly Caucasian. 
                Despite the limitations, this study advances understanding of Vulvodynia pain and 
interference by providing preliminary empirical support for the utility of a biopsychosocial 
model for understanding pain in this population. This study also suggests that efforts to treat 
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Vulvodynia from a purely biomedical perspective may be insufficient, and that pain and 
suffering may be better alleviated by adopting an approach that addresses both physiological 
causes of pain as well as psychosocial factors.  
                In summary, the current study suggests an association between psychological and 
behavioural factors with greater levels of pain severity and interference among women with 
Vulvodynia. Due to the cross-sectional design of the study, conclusion must be drawn with 
caution. Nevertheless, such findings have important implications. Incorporating existing 
empirically supported psychosocial interventions for pain (e.g. cognitive-behavioural therapy) 
into treatment protocols for Vulvodynia may hold promise for enhancing pain management in 
this population. Longitudinal studies are first needed to examine the causal pathways between 
illness perceptions, cognitive-behavioural factors and pain among women with Vulvodynia. 
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Table 1: Summary of demographic factors (n=335) 
    Variable                                                       
    Age (years), Mean ± SD (range)                              34.8 ± 9.6 (18-65) 
    Nationality (Italian), n (%)                                                324 (96.7%) 
    Ethnicity (Caucasian), n (%)                                                315 (94%)   
    Marital status 
        Married, n (%)                                                                85 (25.4%) 
        With partner, n (%)                                                       159 (47.5%) 
        Divorced/separated, n (%)                                                15 (4.5%)   
        Alone, n (%)                                                                   75 (22.4%) 
        Not disclosed, n (%)                                                           1 (0.3%) 
     Employment status 
        Employed, n (%)                                                           196 (58.5%) 
        Student, n (%)                                                                 62 (18.5%) 
        Unemployed, n (%)                                                         62 (18.5%) 
        Not disclosed, n (%)                                                          15 (4.5%) 
     Education 
       Middle School (8 years of school Education), n (%)         14 (4.2%) 
       High School (13 years of school education), n (%)       136 (40.6%) 
       Higher Education, n (%)                                                185 (55.2%) 
  Notes. SD= Standard deviation 
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Table 2: Summary of clinical factors (n=335) 
 
     Variable                                        
Number of years since symptom  onset, Mean, median (IQR)      6.5,  5.0 (5.7)  
     Number of years since diagnosis, Mean, median (IQR)                   3, 2.0 (3.0) 
     Diagnostic Delay (Years)                                                                              3.5 
     Severity of Diagnosis 
         Mild, n (%)                                                                                 15 ± (14.5%) 
         Moderate, n (%)                                                                        147 ± (43.9%) 
         Severe, n (%)                                                                                  95 (28.4%) 
         Not disclosed, n (%)                                                                       78 (23.3%) 
     Currently on Treatment, n (%)                                                         280 (83.6%) 
     Pelvic Floor Dysfunction 
         Suffering, n (%)                                                                           219 (65.4%) 
         Not known, n (%)                                                                          72 (21.5%) 
      Comorbidities 
         Fibromyalgia, n (%)                                                                      35 (10.4%)          
         Irritable Bowel Syndrome, n (%)                                                    26 (7.7%) 
         Endometriosis, n (%)                                                                       12 (3.5%) 
         Hypothyroidism, n (%)                                                                    16 (4.7%) 
         Interstitial cystitis, n (%)                                                                    7 (2%) 
   Notes. SD= standard deviation; IQR= interquartile range 
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Table 3: Correlations between the independent and outcome variables (Pain severity and Pain inter-
ference) 
 
       Mean (S.D) Pain severity Pain interference 
    
Pain severity            17.42 (11.72)                   -             .71** 
Pain Interference            32.29 (19.26)                     .71**       - 
HADS              18.25 (8.04) .49**            .62** 
CFQ                6.08 (3.93) .29**            .44** 
CBSQ    
   Fear-avoidance              13.71 (5.02)                    .13* .30** 
   Catastrophizing                8.26 (4.07) .43**                .47** 
   Embarrassment-avoidance              11.01 (6.56) .27**                .39** 
   All-or-nothing Behaviour                7.34 (5.23)                   .17*                .28** 
   Avoidance/resting Behaviour              11.25 (6.66) .27**                .44** 
   Symptom focusing              17.54 (4.71)                     .34**                .40** 
   Damage 
IPQ-R 
   Identity 
   Acute-chronic timeline 
   Consequences 
   Personal control 
   Treatment control 
   Illness Coherence 
   Cyclical timeline 
   Emotional representation                
             12.24 (3.61) 
 
3.89 (3.02) 
            22.54 (3.82) 
            23.39 (4.11) 
19.81 (4.35) 
17.13 (3.80) 
14.67 (4.91) 
14.58 (3.67) 
24.58 (4.62) 
 .30** 
 
.27** 
                  .16* 
                    .31** 
-.25** 
-.36** 
-.19** 
  -.01 
           .29** 
        
               .31** 
 
               .33** 
            .12* 
               .40** 
              -.19** 
              -.32** 
              -.28** 
             .12* 
               .33** 
    
Notes. *p<.05; **p<.01 HADS= Hospital Anxiety and Depression Scale; CFQ= Chalder Fatigue 
questionnaire; CBSQ= Cognitive Behavioural Symptom Questionnaire; IPQ-R= Illness perception 
Questionnaire Revised 
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Table 4: Hierarchical regression model for pain severity 
 
  Block 1 Block 2 
Variable Beta (s.e) 95% CI Beta (s.e) 95% CI 
 Age -.14 (.70)* -.28, .00 -.13 (.06)* -.25, -0.01 
 Education -3.69 (1.28)* -6.21, -1.16 -1.74 (1.31) -3.96, .49 
 Years with symptoms 0.03 (0.10) -.17, .23 .08 (.09) -.10, .26 
 Comorbidity 1.78 (.56)** .69, 2.89 .12 (.52) -.92, 1.15 
 Distress   .46 (.10)** .26, .66 
 Catastrophizing   40 (.20)* .01, .78 
 Fatigue   -.04 (.17) -.29, .36 
 EA   -.13 (.10) -.33, .08 
 A/R behaviour   .01 (.10) -.20, .20 
 Illness Identity   .49 (.22)* .06, .91 
 Consequences   .02 (.17) -.31, 0.36 
 Personal control   -.27 (.14)a -.56, .01 
 Treatment control   -.52 (.18)* -.88, -.16 
 Damage beliefs   -.04 (.20) -.43, .34 
 Symptom focusing   .07 (.16) -.24, .37 
 
Notes. *p<.05; **p<.01; CI= confidence intervals; SE= standard error; B= unstandardized beta coeffi-
cient; β= standardised beta coefficient; EA= embarrassment-avoidance; A/R Behaviour= avoidance/resting 
behaviour ap=0.06 
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Table 5: Hierarchical regression for pain interference  
 
 
  Block 1 Block 2 
Variable Beta (s.e) 95% CI Beta (s.e) 95% CI 
 Age -.21 (.11) -.44, .01 -.16 (.09) -.34, .02 
 Education -5.62 (2.08)* -9.72, -1.52 -2.76 (1.64) -6.0, .48 
 Years with symptoms  -.03 (.17) -.36, .30 .13 (.13) -.13, .39 
 Comorbidity 3.98 (.92)** 2.17, 5.78 1.03 (.77) -.48, 2.55 
 Distress   .91 (.15)** .61, 1.21 
 Catastrophizing   .27 (.29) -.31, .85 
 Fatigue   .57 (.25)* .09, 1.05 
 Fear-avoidance   .32 (.18) -.05, .68 
 Damage   -.37 (.29) -.95, .21 
 EA   -.05 (.16) -.36, .27 
 Symptom focusing   .12 (.23) -.34, .58 
 A/N Behaviour   -.05 (.18) -.41, .30 
 A/R behaviour   .37 (16)* .05, .69 
 Illness Identity   .37 (.32) -.25, .1.0 
 Consequences   .05 (.25) -.44, .54 
 Treatment control   -.59 (.26)* -1.10, -.08 
 Illness Coherence   -.26 (.19) -.63, .12 
 
 
  
Notes. *p<0.05; **p<0.01; CI= confidence intervals; SE= standard error; B= unstandardized beta 
coefficient; β= standardised beta coefficient; A/R behaviour= avoidance-resting behaviour 
